Recombinant multi-species APOBEC3G protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APOBEC3G protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. The protein encoded by this gene catalyzes site-specific deamination of both RNA and single-stranded DNA. The encoded protein has been found to be a specific inhibitor of human immunodeficiency virus-1 (HIV-1) infectivity. [provided by RefSeq, Mar 2017]
The Alternative Names of target: A3G,APOBEC-related cytidine deaminase (APOBEC-related protein,APOBEC-related protein 9 (ARP-9),APOBEC3G,ARCD,ARCD),ARP-9,ARP9,CEM-15,CEM-15 (CEM15),CEM15,DNA dC->dU-editing enzyme APOBEC-3G,Deoxycytidine deaminase (A3G),MDS019,bK150C2.7,dJ494G10.1

Target products collectionGo to APOBEC3G products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10925-Ag-1/ GM-Tg-hg-IP10925-Ag-2 Human APOBEC3G protein Human
GM-Tg-rg-IP10925-Ag-1/ GM-Tg-rg-IP10925-Ag-2 Rat APOBEC3G protein Rat
GM-Tg-mg-IP10925-Ag-1/ GM-Tg-mg-IP10925-Ag-2 Mouse APOBEC3G protein Mouse
GM-Tg-cynog-IP10925-Ag-1/ GM-Tg-cynog-IP10925-Ag-2 Cynomolgus/Rhesus macaque APOBEC3G protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10925-Ag-1/ GM-Tg-felg-IP10925-Ag-2 Feline APOBEC3G protein Feline
GM-Tg-cang-IP10925-Ag-1/ GM-Tg-cang-IP10925-Ag-2 Canine APOBEC3G protein Canine
GM-Tg-bovg-IP10925-Ag-1/ GM-Tg-bovg-IP10925-Ag-2 Bovine APOBEC3G protein Bovine
GM-Tg-equg-IP10925-Ag-1/ GM-Tg-equg-IP10925-Ag-2 Equine APOBEC3G protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10925-Ag-1/ GM-Tg-hg-IP10925-Ag-2; GM-Tg-rg-IP10925-Ag-1/ GM-Tg-rg-IP10925-Ag-2;
GM-Tg-mg-IP10925-Ag-1/ GM-Tg-mg-IP10925-Ag-2; GM-Tg-cynog-IP10925-Ag-1/ GM-Tg-cynog-IP10925-Ag-2;
GM-Tg-felg-IP10925-Ag-1/ GM-Tg-felg-IP10925-Ag-2; GM-Tg-cang-IP10925-Ag-1/ GM-Tg-cang-IP10925-Ag-2;
GM-Tg-bovg-IP10925-Ag-1/ GM-Tg-bovg-IP10925-Ag-2; GM-Tg-equg-IP10925-Ag-1/ GM-Tg-equg-IP10925-Ag-2
Products Name APOBEC3G protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name APOBEC3G
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APOBEC3G protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.